CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Scientists from Albert Einstein College of Medicine and Utrecht University, conducted a research study about the impact of ...

Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for subsequent long COVID, according to a study published ...

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated ...

A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...

New data from the UK and the US reveal a broad and significant rise in gut-brain disorders, including IBS and functional ...

Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of ...

Respiratory infections like Covid-19 and flu may reactivate dormant breast cancer cells in the lungs, increasing metastatic ...

New research shows COVID-19 and flu infections can reactivate dormant breast cancer cells in the lungs, significantly ...

A study, led by scientists from the University of Colorado Anschutz Medical Campus, looked at how viruses could awaken ...